Strategic planning in the life sciences and other technology sectors often relies on specific assumptions about future events, including regulatory changes to market demand for innovations. However, poorly vetted assumptions can lead to strategic roadblocks, affecting compliance, IP security and growth. At Crowley Law LLC, we understand the importance of setting sound assumptions to drive strategic goals and mitigate risks unique to life sciences and other technology. We are dedicated to helping our clients develop and review strategic planning assumptions that align with their strategic objectives and foster sustainable growth.
In strategic planning, assumptions are the foundational beliefs or projections a company holds about its future operating environment. They inform decision-making and shape the broader business strategy.
Assumptions about regulatory approval timelines, research and development (“R&D”) breakthroughs and market demand must be carefully vetted to avoid unrealistic expectations. While some assumptions may lack full data support, validating them with industry insights helps ensure they remain well-founded and actionable.
Each organization and market has unique factors to consider and there is no universal set of assumptions that applies to all. We recommend focusing on these areas when setting strategic assumptions:
Carefully evaluate political, economic, technological and regulatory factors that could impact operations. For instance, changes in Food and Drug Administration (“FDA”) regulations or global biotech market trends may significantly affect your strategic planning assumptions.
Assess your organization’s strengths and resources, such as R&D capacity, talent pool and financial resilience, to ensure your assumptions about growth and scalability are grounded.
Ensure that strategic assumptions align with your overarching goals, such as achieving specific clinical milestones or market entry timelines to reflect realistic outcomes.
Account for the interests of key stakeholders, including investors, regulatory bodies and clinical partners, whose support is crucial to successful strategy execution.
Analyze your current and potential competitors, assessing how they may respond to your strategic initiatives and market positioning efforts. Knowing your competitive landscape helps set realistic assumptions about market share and innovation capacity.
While strategic assumptions can simplify complex situations and guide decision-making, they also carry risks, including potential compliance issues, missed research opportunities and biases. These risks underscore the importance of regularly reviewing assumptions to ensure they support informed and adaptable strategic planning. We recommend the following five-step process for evaluating assumptions:
Begin by identifying each strategic assumption within your other technology business model. Use the considerations from the previous section to organize these assumptions and consider tools like fishbone diagrams, SWOT analyses and PESTEL analyses specifically tailored to your industry. For instance, a SWOT analysis could assess assumptions about FDA regulatory timelines, while a PESTEL analysis could help evaluate market readiness. Consider asking questions such as:
Next, evaluate the validity of each assumption by checking its alignment with real-world evidence and reliable data. For other technology firms, this might involve validating assumptions with clinical trial data, patent landscape analyses or regulatory precedents. You might also ask:
Assessing the relevance of your assumptions involves determining how well they align with your organization’s unique biotech context. Tools like the value proposition canvas and stakeholder analysis can help. Consider these questions to ensure your assumptions remain relevant:
The final step is to evaluate the impact of each assumption, particularly how it influences the outcomes and risks of your strategic plan. Tools like balanced scorecards, cost-benefit analyses and risk matrices are helpful in assessing potential impacts on areas like regulatory compliance and clinical trial budgets. To measure impact effectively, consider:
Life sciences and other technology are fast-paced industries, often facing unique legal and regulatory challenges that complicate the strategic planning process. At Crowley Law LLC, we partner with you to build and implement a strategic plan founded on well-informed, meaningful assumptions. Our services include:
Our team assists life sciences and other technology companies in reviewing strategic assumptions to ensure they align with relevant regulatory landscapes, such as FDA and European Medicines Agency (“EMA”) guidelines. By proactively addressing regulatory compliance, we help minimize risks and liabilities, safeguarding your business as it navigates complex approval processes.
We help ensure that your strategic assumptions include robust IP strategies, such as securing patents for proprietary technologies or genetic research. By protecting these innovations, you establish a strong foundation for your company’s growth and market advantage.
Contracts for R&D collaborations and clinical trial agreements are foundational to growth. Our team helps review assumptions related to these agreements, ensuring they are legally sound, enforceable and aligned with your strategic business goals, setting the stage for successful and compliant collaborations.
Mergers and acquisitions require a thorough evaluation of factors like IP portfolios, research pipelines and regulatory compliance. We assist clients in assessing these strategic assumptions from a legal perspective, guiding them through the due diligence process and preparing for negotiations that seek to maximize value while minimizing risks.
No, it is impossible to completely avoid making strategic assumptions when developing a strategic plan. These assumptions form the foundation of planning, addressing future conditions like regulatory changes, research outcomes and market demands that will guide your business strategy.
Reviewing strategy assumptions involves critically evaluating the foundational premises that shape your strategic plan. In other technology, this means assessing expectations around regulatory timelines, research advancements and market conditions to ensure each assumption supports sound, future-focused decision-making.
Crowley Law LLC is proud to support Hope Through Education and their mission is to help thousands of underprivileged students reach their full potential through the gift of a great education. Learn more about this organization.
